The Paediatric team is both part of the Newcastle ECMC with a specific focus to run early phase clinical trials for adolescents and young adults (AYA) across both sites; and part of the national paediatric ECMC Network.
It is also an accredited early phase clinical trials centre of the European network Innovative Therapies for Children with Cancer (ITCC). To further facilitate our ability to offer novel therapies to children and young people in the North we have recently founded an early phase clinical trials network with Glasgow, Edinburgh, Aberdeen and Belfast, the Phase I Northern ChiLDrEn’s Cancer Network (INCLuDE).
Facilities to accommodate families who need to travel to Newcastle are available.
The Newcastle Cancer Centre hosts one of the largest translational research programmes in paediatric oncology (both leukaemia and solid tumours) in Europe. Our researchers have developed strong links with the CR-UK funded Newcastle Drug Discovery Programme and the Sir Bobby Robson Cancer Trials Research Centre to create new therapies against targets and develop trials in paediatric malignancies. The CR-UK funded paediatric tumour biobank is also housed in Newcastle.
The Newcastle Paediatric Centre is linked with Birmingham's Cancer Research UK Clinical Trials Unit.
The Experimental Cancer Medicine Centre initiative is jointly funded by Cancer Research UK, the National Institute for Health Research in England and the Departments of Health for Scotland, Wales and Northern Ireland.